Title: Octopus-AIM-VCT2-factsheet-retail-CAM015869-2605_v1.indd URL Source: https://documentscdn.financialexpress.net/Literature/5FAC46F246F6096E2233CDC2E8AD9025/242396898.pdf Number of Pages: 2 Markdown Content: Octopus AIM VCT 2 plc factsheet # Data as at 30 April 2026 About the Product Octopus AIM VCT 2 plc is a Venture Capital Trust (VCT) which aims to provide shareholders with attractive tax-free dividends and long-term capital appreciation by investing in a diverse portfolio of predominantly AIM-quoted companies. Risk is spread by investing in a number of different businesses across a range of activities and sectors. Five year performance (%) -60 -40 -20 020 40 60 80 100 Apr 26 Apr 25 Apr 24 Apr 23 Apr 22 Apr 21 Cumulative performance to 30 April 2026 (%) > Calendar year YTD 3 Y 5 Y 2025 2024 2023 Octopus AIM VCT 2 NAV TR -2.15 -12.46 -40.70 0.25 -1.24 -11.74 ● Octopus AIM VCT 2 Share Price TR -0.63 -9.38 -40.68 1.10 0.23 -11.60 ● FTSE AIM All-Share TR 4.04 1.19 -32.92 8.53 -3.95 -6.40 ● FTSE All-Share TR 5.25 44.74 66.87 24.02 9.47 7.92 Discrete yearly performance (%) Year to 30 April 2026 2025 2024 2023 2022 Octopus AIM VCT 2 NAV TR 5.52 -8.13 -9.04 -18.55 -19.10 ● Octopus AIM VCT 2 Share Price TR 9.49 -10.78 -7.23 -20.74 -17.42 ● FTSE AIM All-Share TR 17.01 -7.46 -6.55 -17.49 -19.65 ● FTSE All-Share TR 25.21 7.53 7.50 6.04 8.72 > Source: Lipper and Octopus Investments. VCT performance is shown as a simple return comparison between the NAV at the beginning of the period and the NAV, plus any dividends paid out, at the end of the period. VCT share price performance shown includes reinvested dividends. NAV is stated after deduction of fees. Key risks • The value of investments discussed, and any income from them, can fall as well as rise. Investors may not get back the full amount they invest. • Tax treatment depends on an investor’s personal circumstances and may change in the future. • Tax reliefs depend on the VCT maintaining its VCT-qualifying status. • VCT shares could fall or rise in value more than other shares listed on the main market of the London Stock Exchange. They may also be harder to sell. • Past performance is not a reliable indicator of future results. About the Team Freda Isingoma Mark Symington Dominic Weller Kate Tidbury The Octopus AIM VCTs are managed by the Quoted Companies team who have significant experience across the mid and small cap investment universe and is one of the largest investors in AIM. The team includes Kate Tidbury, Freda Isingoma, Mark Symington, Dominic Weller, Richard Power, Edward Griffiths, Chris McVey, Jessica Bourdon-Pierre, Ross MacSween, Georgia Obadipe, Charles Lucas, Ben Tyson and Abi Scott. Key facts Net assets £68.2m Market cap £65.6m Shares issued 220.2m Launch date 2005 Benchmark FTSE AIM All-Share TR Number of holdings 69 Year end 30 November Current Price NAV per share * 31.0p Share price (mid) 29.8p > *NAV reported weekly. Share buybacks: The VCT can buy back up to 14.99% of the share capital annually at up to a 5% discount, subject to Board and shareholder approval. Glossary Net Asset Value (NAV) The value of the Company’s total assets less liabilities. NAV per share The NAV divided by the total number of shares in issue. Total Return (TR) Total return is calculated as movement in NAV per share in the period plus dividends paid in the period. Investment enquiries To speak to any of our fund managers, please call: 0800 316 2295 investorsupport@octopusinvestments.com octopusinvestments.com Monthly commentary The Net Asset Value (NAV) of the Octopus AIM VCT2 increased by 5.47% during the month. This compares to a 10.86% increase in the FTSE AIM All Share and a 2.77% rise in the FTSE All Share, both on a Total Return basis. April 2026 saw risk appetite improve across UK equities as investors looked through lingering policy uncertainty and mixed global growth signals, with sentiment supported by stabilising interest rate expectations and a rebound in smaller company activity. Against this backdrop, the AIM market performed strongly, led by stock specific updates and valuation re rating across growth names. Top contributors to performance were driven by a broad range of positive stock specific moves. Netcall plc (+20.20%), a leading provider of intelligent automation solutions and customer engagement software, rose following continued momentum in its cloud software offering, with improving visibility on contract wins supporting sentiment. Veterinary pharmaceutical and services business Animalcare Group plc (+45.61%) delivered a strong rebound as investors responded to signs of stabilising trading and operational progress. However, in the same period, a recommended cash offer (from a Bidco) was unanimously accepted by the board of directors. Haydale plc (+25.47%), the advanced materials and clean-technology group, benefited from renewed interest in advanced materials exposure, while also announcing an expanded partnership and exclusive multi year framework agreement with Wave Utilities. Ilika plc (+37.50%), a developer of solid state batteries, also contributed meaningfully as investor interest returned to battery and solid state technology themes. Healthcare software solutions business, Craneware plc (+14.59%) advanced on confidence in the resilience of healthcare IT spending. Detractors to performance over the month were more concentrated. Transport technology solutions business, Aurrigo International plc (-13.41%), weakened as near term order timing uncertainty weighed on sentiment, despite longer term automation opportunities. IXICO plc (-12.70%), global leader in neuroscience imaging and biomarker analytics, declined amid ongoing caution around contract visibility in imaging analytics. KRM22 plc (-11.27%), a technology and software investment company, fell on subdued demand conditions across risk and compliance software. Clinical infrastructure specialist Feedback plc (-25.00%), also weakened following operational updates that highlighted a central NHS contract decision remains delayed, despite positive discussions continuing. Despite the still uncertain macro environment and geopolitical events, we are hopeful May will see a continuation of improving confidence, supporting a broader re rating across quality AIM growth names. Tax-free dividend payments over last five years 02468FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 Dividend value (p) ● Dividend (p) ● Special dividend (p) Interim (p) 2 > Based on ex-dividend dates per financial year 30 November 2025. Top ten holdings (%) FP Octopus UK Micro Cap Growth P Acc 6.9 Popsa Holdings Limited 5.3 Animalcare Group plc 4.2 Netcall plc 3.8 Craneware plc 3.5 IDOX plc 3.4 FP Octopus UK Multi Cap Income S Acc 2.7 Aurrigo International plc 2.5 FP Octopus UK Future Generations C Acc 2.4 Abingdon Health plc 2.1 Total 36.8 Top ten sectors (%) Software & Computer Services 16.5 Unit Trusts 12.0 Unquoted Investment 5.6 Food Producers & Processors 4.9 Pharmaceuticals & Biotech 4.8 Health 4.6 Chemicals 3.7 Electronic & Electrical 3.1 General Retailers 2.6 Specialty & Other Finance 2.6 Total 60.5 5-year dividend history Pay Date Type Div. per share 21 May 2021 Final 2.10p 12 Nov 2021 Special 1.70p 12 Nov 2021 Interim 2.10p 27 May 2022 Final 2.10p 10 Nov 2022 Interim 2.10p 25 May 2023 Final 2.30p 09 Nov 2023 Interim 1.80p 27 Jun 2024 Special 3.60p 27 Jun 2024 Final 1.80p 28 Nov 2024 Interim 1.80p 29 May 2025 Final 1.80p 27 Nov 2025 Interim 1.80p 01 Apr 2026 Special 3.60p > The Board targets a minimum dividend of 1.8p each half year with the final adjusted annually, based on the year-end share price, so that shareholders receive either 5p per annum or a 5% yield, whichever is greater at the time. Fees & codes Management fee 2.00% Total ongoing charges * 2.40% ISIN code GB00B0JQZZ80 Sedol code B0JQZZ8 Ticker (LSE) OSEC > * Calculated as at 30 November 2025. Directors Keith Mullins (Chair) Andy Raynor Brad Ormsby Virginia Bull Due to rounding, tables may not sum correctly. Important information Personal opinions may change and should not be seen as advice or a recommendation. We do not offer investment or tax advice. We recommend investors seek professional advice before deciding to invest. Regarding VCTs, this advertisement is not a prospectus and you should only subscribe for shares on the basis of information contained in the prospectus and the Key Information Document. For other investments, investors should read the product brochure before deciding to invest. These documents are available at octopusinvestments.com. Issued by Octopus Investments Limited, which is authorised and regulated by the Financial Conduct Authority. Registered office: 33 Holborn, London, EC1N 2HT. Registered in England and Wales No. 03942880. We record telephone calls. Issued: May 2026. CAM015869.